A major bipartisan Senate 340B program overhaul, called the SUSTAIN 340B Act, could be released as soon as early September [...] …
Articles by : William Newton, Associate Editor/Senior Writer
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A powerful brand name drug industry trade group has filed suit against a Kansas law prohibiting drugmaker 340B contract pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical giant Johnson & Johnson (J&J) is exempting covered entities in Maryland and Mississippi from its contract pharmacy restrictions, marking [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Eligible providers in Florida, Georgia and South Carolina can now immediately enroll in the 340B program without waiting for the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Minnesota Gov. Tim Walz, Vice President Kamala Harris’ Democratic running mate in the U.S. presidential race, has been a vocal [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A state hospital-backed candidate won Tuesday’s Missouri Republican gubernatorial primary after defeating a high-profile opponent with dark money ties who [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical manufacturers Sanofi, GlaxoSmithKline (GSK) and Viatris are fully or partially exempting additional states from their 340B contract pharmacy restrictions. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Novartis is now the third drug manufacturer to challenge Kansas’ new law prohibiting drug manufacturers from restricting contract pharmacy access [...] …
